ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 17 filers reported holding ARMATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $272,907 | +299.7% | 90,969 | +51.9% | 0.00% | – |
Q2 2023 | $68,275 | -28.5% | 59,890 | +4.7% | 0.00% | – |
Q1 2023 | $95,494 | +75.8% | 57,182 | +30.6% | 0.00% | – |
Q4 2022 | $54,305 | -95.5% | 43,795 | -84.8% | 0.00% | – |
Q3 2022 | $1,213,000 | +14.2% | 287,350 | +5.2% | 0.00% | – |
Q2 2022 | $1,062,000 | -20.4% | 273,150 | 0.0% | 0.00% | – |
Q1 2022 | $1,335,000 | -7.3% | 273,150 | +4.0% | 0.00% | – |
Q4 2021 | $1,440,000 | +136.1% | 262,750 | +55.8% | 0.00% | – |
Q3 2021 | $610,000 | -8.3% | 168,658 | +0.8% | 0.00% | – |
Q2 2021 | $665,000 | +83.7% | 167,378 | +121.4% | 0.00% | – |
Q1 2021 | $362,000 | +704.4% | 75,596 | +399.0% | 0.00% | – |
Q4 2020 | $45,000 | -6.2% | 15,150 | 0.0% | 0.00% | – |
Q3 2020 | $48,000 | -18.6% | 15,150 | 0.0% | 0.00% | – |
Q2 2020 | $59,000 | +25.5% | 15,150 | 0.0% | 0.00% | – |
Q1 2020 | $47,000 | -4.1% | 15,150 | 0.0% | 0.00% | – |
Q4 2019 | $49,000 | -12.5% | 15,150 | 0.0% | 0.00% | – |
Q3 2019 | $56,000 | -8.2% | 15,150 | -0.0% | 0.00% | – |
Q2 2019 | $61,000 | – | 15,151 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SeaCrest Wealth Management, LLC | 13,500 | $65,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 48,400 | $231,000 | 0.00% |
LOOMIS SAYLES & CO L P | 129,956 | $621,000 | 0.00% |
Renaissance Technologies | 123,816 | $592,000 | 0.00% |
ROYAL BANK OF CANADA | 50 | $0 | 0.00% |
VANGUARD GROUP INC | 75,596 | $362,000 | 0.00% |
TCI Wealth Advisors, Inc. | 100 | $0 | 0.00% |
UBS Group AG | 6,017 | $29,000 | 0.00% |
Sowell Financial Services LLC | 109 | $0 | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $3,000 | 0.00% |